Stock Detail
$NVO
Healthcare · 14 tracked mentions in the last 90 days across 6 creators.
Valuation and creator stance reflect the last 90 days. The mention feed below shows the latest tracked mentions across all history.
NVO leans undervalued across 6 creators and 8 classified valuation claims, with 6 direct claims carrying most of the signal.
Creator Evidence
Why creators say this
Explicit claim • strong conviction • basis: fair value gap
I believe the worst is behind us and I reiterate my fair value to $70 to $80 per share and I expect the stock to go higher.
Explicit claim • strong conviction • basis: explicit term
So, you might look at the P/E ratio of 10.5 and be like, sign me up. That seems to be undervalued. Oh my goodness.
Explicit claim • strong conviction • basis: fair value gap
And after I made these revisions, the fair value estimate declined, but it's still well above the current market price. I calculated a fair value of $123 for Novo Notice
Explicit claim • strong conviction • basis: other
they're at a really good valuation right now
Mention History
Latest mentions across all history
Feed